bigfoot biomedical

presented by
Devices & Diagnostics

Abbott-Bigfoot Deal Proves That Diabetes Is a Hot Area for Digital Health Investment

This week, Abbott announced its plans to acquire Bigfoot Biomedical — a startup selling a “smart” insulin pen cap, which collects data from a user’s CGM to help them calculate the right dose. Most analysts were unsurprised to hear of the acquisition given that the two companies have been collaborating for more than six years, but they said the deal reinforces the steady pace of digital innovation in the diabetes care space.

presented by
BioPharma

From Bigfoot Biomedical’s artificial pancreas to the athenahealth accelerator: 5 must-read stories from MedCity News this week

On MedHeads Friday, we covered everything from Dr. Patrick Soon-Shiong’s continued funding for NantBioscience, our site’s exciting new redesign and other trends from the week. Watch the broadcast above, but also review five of the more important topics we looked at this week. 1. Bigfoot Biomedical’s artificial pancreas is emerging from hack mode with a […]